Craig Samuel Donald

This inventor holds 5 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignee: Astrazeneca Ab. Active years: 2005-2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Craig Samuel Donald. Retrieved from https://idiyas.com/inventor/craig-samuel-donald

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 5 (Patent Applications = 2)

EPO Patents = 1 (Patent Applications = 2)

Average Co-Inventor Count = 7.8

ph-index = 1

Forward Citations = 8(Granted Patents)

Location History:

Cheshire, GB (2010)
Macclesfield, GB (2005 - 2018)

Company Filing History:

5 out of 1,534

Astrazeneca Ab

patents

Years Active: 2005-2018

Loading Chart...

5 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10130617 - Chemical compounds (2018-11-20),

2. 9616050 - Chemical compounds (2017-04-11),

3. 9155727 - Chemical compounds (2015-10-13),

4. 7795283 - Oxadiazole derivative as DGAT inhibitors (2010-09-14),

5. 6967216 - Amino substituted dibenzothiophene derivatives for the treatment of disorders mediated by NP Y5 receptor (2005-11-22),

Title: Craig Samuel Donald: Innovator in Chemical Compounds

Introduction

Craig Samuel Donald is a notable inventor based in Macclesfield, GB. He has made significant contributions to the field of chemical compounds, holding a total of 5 patents. His work focuses on the development of pharmaceutical compositions and their applications in treating various disorders.

Latest Patents

Among his latest patents, Craig has developed compounds of Formula (I) or pharmaceutically-acceptable salts thereof. These inventions include processes for their preparation and their use in the treatment of cell proliferative disorders. His innovative approach has the potential to impact the pharmaceutical industry significantly.

Career Highlights

Craig is currently associated with AstraZeneca AB, a leading global biopharmaceutical company. His role at AstraZeneca allows him to work on cutting-edge research and development in the field of pharmaceuticals. His expertise in chemical compounds has been instrumental in advancing the company's product offerings.

Collaborations

Throughout his career, Craig has collaborated with esteemed colleagues, including Robert Hugh Bradbury and David Buttar. These collaborations have fostered a productive environment for innovation and have contributed to the success of their projects.

Conclusion

Craig Samuel Donald is a distinguished inventor whose work in chemical compounds has garnered attention in the pharmaceutical field. His contributions continue to pave the way for advancements in medical treatments.

Profile summary based on public USPTO records.